Granite Bay Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
35,644
+20,197
+131% +$9.7M 1.65% 19
2026
Q1
$7.6M Buy
15,447
+2,270
+17% +$1.23M 1.62% 25
2025
Q4
$7.64M Sell
13,177
-976
-7% -$552K 1.84% 21
2025
Q3
$6.86M Buy
14,153
+486
+4% +$226K 1.79% 23
2025
Q2
$5.54M Buy
13,667
+3,395
+33% +$1.42M 1.78% 22
2025
Q1
$5.11M Buy
10,272
+1,127
+12% +$610K 1.78% 22
2024
Q4
$4.76M Buy
+9,145
New +$5.03M 1.76% 21
2024
Q3
Sell
-7,530
Closed -$4.16M 70
2024
Q2
$4.16M Buy
7,530
+2,677
+55% +$1.53M 2.23% 16
2024
Q1
$2.82M Sell
4,853
-8,197
-63% -$4.6M 1.6% 19
2023
Q4
$6.32M Sell
13,050
-4,275
-25% -$2.07M 0.06% 98
2023
Q3
$9.23M Buy
+17,325
New +$9.23M 0.09% 87

Other funds holding TMO

Granite Bay Wealth Management's TMO Position: Q2 2026 in Review

Granite Bay Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 131% in Q2 2026, buying an estimated $9.7M and bringing the position to 35,644 shares worth $17.9M. The position accounts for 1.65% of the portfolio, ranked #19.

Granite Bay Wealth Management first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Granite Bay Wealth Management held 35,644 shares of Thermo Fisher Scientific worth $17.9M as of Q2 2026.
  • Granite Bay Wealth Management bought 20,197 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.7M.
  • Thermo Fisher Scientific made up 1.65% of Granite Bay Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Granite Bay Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Granite Bay Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.